Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cerebrospinal fluid probenecid studies: a reinterpretation.

R W Cowdry, M H Ebert, D P van Kammen

    Biological Psychiatry
    |November 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia.

    Prostaglandins, leukotrienes, and essential fatty acids·2003
    Same author

    Characterization of human cleaved N-CAM and association with schizophrenia.

    Experimental neurology·2001
    Same author

    Neuroleptic effects on autonomic activity in schizophrenia: between-group and within-subject paradigms and comparisons with controls.

    Schizophrenia bulletin·2001
    Same author

    Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.

    CNS drugs·2001
    Same author

    Confirmation of a two-factor model of premorbid adjustment in males with schizophrenia.

    Schizophrenia bulletin·2001
    Same author

    Abnormal age-related changes of plasma antioxidant proteins in schizophrenia.

    Psychiatry research·2001

    Probenecid

    Area of Science:

    • Neuroscience
    • Pharmacology

    Background:

    • Probenecid is utilized to assess monoamine turnover by blocking metabolite transport from cerebrospinal fluid (CSF).
    • This method assumes complete blockade, leading to increased CSF metabolite levels reflecting parent monoamine turnover.

    Purpose of the Study:

    • To review literature on probenecid-metabolite correlations in CSF.
    • To present data on variations in these correlations across different diagnostic groups.
    • To investigate the impact of these variations on monoamine turnover studies.

    Main Methods:

    • Literature review of studies reporting CSF probenecid and metabolite levels.
    • Analysis of existing data to examine correlations between probenecid and metabolite concentrations.
    • Comparison of correlation patterns across various diagnostic populations.

    Related Experiment Videos

    Main Results:

    • CSF probenecid levels correlate with CSF metabolite levels, indicating incomplete blockade in human studies.
    • Significant variations in probenecid-metabolite correlations were observed across different diagnostic groups.
    • These variations suggest differences in membrane transport characteristics influencing probenecid efficacy.

    Conclusions:

    • The assumption of complete probenecid blockade in CSF is questionable at typical human study concentrations.
    • Cross-diagnostic variations in probenecid-metabolite correlations complicate the interpretation of monoamine turnover.
    • Differences in membrane transport may confound attempts to adjust for probenecid levels in neurochemical research.